When Antibiotics Rewrite the Immune System
A developer's mysterious illness since 2014 began after a course of antibiotics that seemed to break the body's tolerance to everyday inputs. What started as food reactions evolved into sensitivity to medications, including the antihistamines and steroids meant to treat it. The condition has required repeated hospitalizations for malnutrition and has forced the patient onto disability, though there are signs the system may attempt to discontinue benefits as health fluctuates.
The PGD2 Discovery That Challenged Doctors
For years, medical consultations resulted in panic attack attributions whenever symptoms appeared after eating. A turn at a higher‑competence institution changed the trajectory. During an acute reaction, clinicians tested prostaglandin D2 (PGD2) levels — a chemical mediator associated with allergic pathways. The result came back multiple times the upper limit of normal. This finding suggested an allergic disorder rather than psychological origin, though the specific subtype remained unclear. Steroids and antihistamines provided only temporary relief.
Why MCAS Remains Invisible to Most Clinicians
Specialists have suggested mast cell activation syndrome (MCAS) as a possible framework for the symptom complex. However, diagnostic testing for MCAS is described by many patients as "pretty hopeless," and a significant portion of the medical community flatly declines to recognize it as a valid condition. The result is a situation where patients receive contradictory guidance: some providers dismiss the entire presentation, while others identify a mechanism that cannot be reliably confirmed through standard labs. IgE testing for food allergies returns normal, which further complicates classification under conventional allergy criteria.
The Claude Opus Experiment
The patient attempted to use Claude 5.5 Opus to make sense of the medical journey. The experience fell short of expectations. The model repeated back supplied information, offered suggestions to see specialists already consulted, and in some query configurations simply blocked further interaction. No novel insights or treatment pathways emerged from the exchange. The user concluded that the tool, while capable of language generation, provided no meaningful assistance for this particular medical puzzle.
Living Without a Diagnosis in 2026
The illness story includes elements that resonate with broader discussions about immune resilience. The patient's narrative traces the origin to microbiome disruption from repeated antibiotic courses, then to a state where the immune system appears to have lost tolerance. Descriptions of "cannon‑fodder immune system destruction leading to loss of immune tolerance" circulate in patient communities, though no official terminology has gained widespread acceptance. Reactions are unpredictable — a food tolerated one week may provoke a severe response the next. Medications offer no exception; the patient has reacted to drugs typically used to calm the same symptoms they produce. The condition remains without a named classification, leaving the individual to navigate a health system designed for clearer categorical diagnoses.
For now, the path forward involves accepting uncertainty, advocating for oneself within a system that often defaults to dismissal, and continuing to document patterns in the hope that future research may connect the dots between antibiotic exposure, microbiome alteration, and the emergence of immune confusion.